Back to search

Article

Defining cellular determinants of resistance to PD-1 pathway blockade in non-small-cell lung cancer

2024-06-09

Abstract excerpt

<h4>Summary</h4> Despite sustained clinical responses to immune-checkpoint blockade (ICB) therapies in non-small-cell lung cancer (NSCLC), the majority of patients derive no clinical benefits, and the cellular and molecular underpinnings of such resistance remain incompletely understood. To identify cell types that may influence immunotherapy responses, we first integrated newly generated and previously published...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
19563abe-0de2-5478-aeec-a2cdc6d89189
DOI
10.1101/2024.06.06.597777
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Defining cellular determinants of resistance to PD-1 pathway blockade in non-small-cell lung cancerDOI 10.1101/2024.06.06.597777
Select a neighboring publication to make it the new centre.